This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Dara Biosciences, Inc., Glaxo Wellcome Inc.. Active years: 2000-2016.
Company Filing History:
Years Active: 2000-2016
Title: Kenneth James Ingold: Innovator in Pharmaceutical Composition
Introduction
Kenneth James Ingold is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in pain management. With a total of 2 patents, Ingold's work focuses on innovative solutions for treating pain.
Latest Patents
Ingold's latest patents include a groundbreaking invention titled "Treating or preventing pain using spicamycin derivatives." This invention relates to a pharmaceutical composition comprising spicamycin derivatives that vary in their fatty acid side chain moieties and are useful in the treatment of pain. The invention further provides a method of using the pharmaceutical composition to treat pain, including neuropathic pain. Another significant patent is "Process for resolving mixtures of carbocyclic stereoisomers," which showcases his expertise in pharmaceutical chemistry.
Career Highlights
Throughout his career, Kenneth James Ingold has worked with prominent companies such as Dara Biosciences, Inc. and Glaxo Wellcome Inc. His experience in these organizations has contributed to his development as an inventor and has allowed him to make impactful advancements in the pharmaceutical industry.
Collaborations
Ingold has collaborated with notable individuals in his field, including John R. Didsbury and Linda Goff Jet. These partnerships have likely enriched his work and expanded the scope of his inventions.
Conclusion
Kenneth James Ingold is a distinguished inventor whose contributions to pharmaceutical compositions have the potential to improve pain management significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.